Sanofi SEC filings SNYNF
Sanofi has 1,001 filings in SEC EDGAR's recent list, going back to Jul 29, 2010. Its latest annual report, Form 20-F, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 13F-HR | Filing | Nov 5, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Sep 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 26, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Oct 1, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| N-PX | Filing | Aug 25, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 3 | Initial insider ownership | Aug 12, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 6, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Aug 4, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jun 30, 2026 |
| 13F-HR | Filing | Jul 28, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 27, 2026 | Jul 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 22, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 17, 2026 | Jul 17, 2026 |
| 6-K | Current report (foreign issuer) | Jul 7, 2026 | Jul 7, 2026 |
| 11-K | Employee savings plan report | Jun 30, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 30, 2026 | Dec 31, 2025 |
| NT 11-K | Filing | Jun 30, 2026 | Dec 31, 2025 |
| NT 11-K | Filing | Jun 30, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 24, 2026 | Jun 24, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 12, 2026 | Jun 12, 2026 |
| 6-K | Current report (foreign issuer) | Jun 8, 2026 | Jun 8, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2026 | — |
| 6-K | Current report (foreign issuer) | May 27, 2026 | May 27, 2026 |
| 13F-HR | Filing | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 6-K | Current report (foreign issuer) | May 5, 2026 | May 5, 2026 |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 31, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| 6-K | Current report (foreign issuer) | Mar 4, 2026 | Mar 4, 2026 |
| 6-K | Current report (foreign issuer) | Mar 3, 2026 | Mar 3, 2026 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| IRANNOTICE | Filing | Feb 17, 2026 | — |
| 20-F | Annual report (foreign issuer) | Feb 17, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 17, 2026 | Feb 17, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 13F-HR | Filing | Feb 11, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Feb 10, 2026 |
| SC TO-T/A | Filing | Feb 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 6, 2026 | Feb 6, 2026 |
| S-8 POS | Filing | Feb 5, 2026 | — |
| SC TO-T/A | Filing | Jan 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 29, 2026 | Dec 31, 2025 |
| SC TO-T/A | Filing | Jan 28, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 23, 2026 | Jan 23, 2026 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| SC TO-T | Filing | Jan 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 9, 2026 | Jan 9, 2026 |
| SC TO-C | Filing | Dec 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 23, 2025 | Dec 23, 2025 |
| 6-K | Current report (foreign issuer) | Dec 22, 2025 | Dec 22, 2025 |
| 6-K | Current report (foreign issuer) | Dec 15, 2025 | Dec 15, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 12, 2025 |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 13F-HR | Filing | Nov 4, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 31, 2025 | Oct 31, 2025 |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 28, 2025 | Oct 28, 2025 |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| 424B5 | Prospectus supplement | Oct 27, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 27, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Oct 24, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Oct 24, 2025 | Oct 24, 2025 |
| 6-K | Current report (foreign issuer) | Oct 15, 2025 | Oct 15, 2025 |
| 6-K | Current report (foreign issuer) | Sep 26, 2025 | Sep 26, 2025 |
| 6-K | Current report (foreign issuer) | Sep 22, 2025 | Sep 22, 2025 |
| 6-K | Current report (foreign issuer) | Sep 17, 2025 | Sep 17, 2025 |
| 6-K | Current report (foreign issuer) | Sep 4, 2025 | Sep 4, 2025 |
| 6-K | Current report (foreign issuer) | Sep 3, 2025 | Sep 3, 2025 |
| 6-K | Current report (foreign issuer) | Aug 29, 2025 | Aug 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Jul 31, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 31, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 31, 2025 | Jul 31, 2025 |
| N-PX | Filing | Jul 30, 2025 | Jun 30, 2025 |
| 13F-HR | Filing | Jul 29, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| 6-K | Current report (foreign issuer) | Jul 18, 2025 | Jul 18, 2025 |
| SC TO-T/A | Filing | Jul 18, 2025 | — |
| SC TO-T/A | Filing | Jul 17, 2025 | — |
| SC TO-T/A | Filing | Jul 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 2, 2025 | Jul 2, 2025 |
| 11-K | Employee savings plan report | Jun 27, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 27, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Jun 24, 2025 | Jun 24, 2025 |
| 6-K | Current report (foreign issuer) | Jun 18, 2025 | Jun 18, 2025 |
| 6-K | Current report (foreign issuer) | Jun 17, 2025 | Jun 17, 2025 |
| SC TO-T | Filing | Jun 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 6, 2025 | Jun 6, 2025 |
| SC TO-C | Filing | Jun 3, 2025 | — |
| SC TO-C | Filing | Jun 2, 2025 | — |
| SC TO-C | Filing | Jun 2, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | May 30, 2025 | May 30, 2025 |
| 6-K | Current report (foreign issuer) | May 22, 2025 | May 22, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 13F-HR | Filing | May 6, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 24, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 22, 2025 | Apr 22, 2025 |
| 6-K | Current report (foreign issuer) | Apr 16, 2025 | Apr 16, 2025 |
| 6-K | Current report (foreign issuer) | Apr 10, 2025 | Apr 10, 2025 |
| 6-K | Current report (foreign issuer) | Apr 4, 2025 | Apr 4, 2025 |
| 6-K | Current report (foreign issuer) | Apr 2, 2025 | Apr 2, 2025 |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 26, 2025 | Mar 26, 2025 |
| S-8 POS | Filing | Mar 21, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 20, 2025 | Mar 20, 2025 |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2025 | Mar 6, 2025 |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Current report (foreign issuer) | Feb 20, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 13F-HR | Filing | Feb 14, 2025 | Dec 31, 2024 |
| IRANNOTICE | Filing | Feb 13, 2025 | — |
| 20-F | Annual report (foreign issuer) | Feb 13, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 13, 2025 | Feb 13, 2025 |
| 6-K | Current report (foreign issuer) | Feb 7, 2025 | Feb 7, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Jan 30, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 24, 2025 | Jan 24, 2025 |
| 6-K | Current report (foreign issuer) | Jan 14, 2025 | Jan 14, 2025 |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Dec 13, 2024 | Dec 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2024 | Nov 7, 2024 |
| 6-K | Current report (foreign issuer) | Oct 31, 2024 | Oct 31, 2024 |
| 6-K | Current report (foreign issuer) | Oct 25, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Oct 21, 2024 | Oct 21, 2024 |
| 6-K | Current report (foreign issuer) | Oct 11, 2024 | Oct 11, 2024 |
| 6-K | Current report (foreign issuer) | Oct 2, 2024 | Oct 2, 2024 |
| 6-K | Current report (foreign issuer) | Sep 24, 2024 | Sep 24, 2024 |
| 6-K | Current report (foreign issuer) | Sep 13, 2024 | Sep 13, 2024 |
| 6-K | Current report (foreign issuer) | Sep 3, 2024 | Sep 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 13, 2024 | — |
| 3 | Initial insider ownership | Aug 13, 2024 | Aug 12, 2024 |
| 6-K | Current report (foreign issuer) | Aug 13, 2024 | Aug 13, 2024 |
| 6-K | Current report (foreign issuer) | Jul 25, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jul 25, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jul 23, 2024 | Jul 23, 2024 |
| 6-K | Current report (foreign issuer) | Jul 2, 2024 | Jul 2, 2024 |
| 11-K | Employee savings plan report | Jun 28, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 28, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Jun 11, 2024 | Jun 11, 2024 |
| SC 13G | Ownership over 5% (passive) | May 31, 2024 | — |
| 6-K | Current report (foreign issuer) | May 30, 2024 | May 30, 2024 |
| 6-K | Current report (foreign issuer) | May 28, 2024 | May 28, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2024 | — |
| 6-K | Current report (foreign issuer) | May 2, 2024 | May 2, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Mar 31, 2024 |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 24, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2024 | — |
| F-3ASR | Filing | Apr 4, 2024 | — |
| S-8 | Employee stock plan registration | Apr 4, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 20, 2024 | Mar 20, 2024 |
| S-8 POS | Filing | Mar 15, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 27, 2024 | Feb 27, 2024 |
| IRANNOTICE | Filing | Feb 23, 2024 | — |
| 20-F | Annual report (foreign issuer) | Feb 23, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Feb 15, 2024 | Feb 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 2, 2024 | Feb 2, 2024 |
| 6-K | Current report (foreign issuer) | Feb 1, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Jan 23, 2024 | Jan 23, 2024 |
| 6-K | Current report (foreign issuer) | Jan 17, 2024 | Jan 17, 2024 |
| 6-K | Current report (foreign issuer) | Dec 27, 2023 | Dec 27, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SNY (Nasdaq), SNYNF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris, France
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1121404
- Former names
- SANOFI-AVENTIS (until May 9, 2011); SANOFI SYNTHELABO SA (until Aug 24, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.